CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $115,000 | -50.2% | 457,209 | +5.0% | 0.02% | -39.5% |
| Q1 2022 | $231,000 | +17.9% | 435,285 | +36.6% | 0.04% | +26.7% |
| Q4 2021 | $196,000 | -33.6% | 318,668 | +10.0% | 0.03% | -33.3% |
| Q3 2021 | $295,000 | -94.4% | 289,627 | -90.0% | 0.04% | -94.4% |
| Q2 2021 | $5,278,000 | +23.9% | 2,884,251 | +33.4% | 0.81% | +7.7% |
| Q1 2021 | $4,259,000 | +5898.6% | 2,162,029 | +3697.6% | 0.75% | +4587.5% |
| Q4 2020 | $71,000 | +57.8% | 56,932 | +128.7% | 0.02% | +23.1% |
| Q3 2020 | $45,000 | -67.4% | 24,890 | +51.5% | 0.01% | -71.7% |
| Q2 2020 | $138,000 | +137.9% | 16,434 | +49.5% | 0.05% | +91.7% |
| Q1 2020 | $58,000 | – | 10,995 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |